Defence acceleration and margin expansion into focus as momentum sustains
Solar Industries reports Q2 FY27 on Nov 3. After a record Q1 (+70% revenue, +89% profit), the question is whether the defence-led surge continues. Market watching execution on guidance, Omnia integration setup, and whether margins hold.
What to Expect: The Metric Setup
~₹3,500 Cr
On-plan if Q1 momentum holds. FY27 guide is ₹14,000 Cr; at current run-rate achievable.
~₹600 Cr
Assume Q1's 18.2% net margin; a dip signals working-capital or mix headwind.
~28–30%
Q1 set high bar. Operating leverage from defence, but watch if Omnia integration costs show.
~₹1,050–1,150 Cr
Core growth driver. FY27 target: ₹4,500 Cr (50% growth). Q2 will reveal execution pace.
A strong quarter means Solar holds or exceeds ₹3,600 Cr revenue on ₹18%+ net margins, with defence contributions inline with FY27's 50% growth thesis. A weak quarter would be ₹3,200 Cr or lower, or margin compression below 17%, suggesting either operational delays or inventory build ahead of a seasonal slowdown. The Street is watching whether the company can translate order-book visibility (₹21,350 Cr) into consistent execution across Q2–Q4.
Is the Guidance On Track?
Yes. Q1's ₹3,668 Cr revenue (+70% YoY) and ₹666 Cr profit (+89% YoY) put Solar well ahead of the ₹14,000 Cr FY27 target (₹3,500 Cr quarterly run-rate needed). The company also raised its defence revenue guidance to ₹4,500 Cr for FY27, up from ₹3,000 Cr, underpinned by strong order inflows and India's defence indigenization tailwind. However, the bar is now higher: Q2 must sustain momentum without anomalies (such as lumpy orders pulling forward). The ₹21,350 Cr order book provides high visibility, but Q2–Q4 execution—especially integrating the Omnia acquisition and scaling international operations—will define full-year credibility.
What the Street Says
Since Last Quarter: Filings & Corporate Activity
Oct 27
Nov 3 board meeting to approve Q2 FY27 results — routine, on schedule.
Board Meeting Notice
Oct 15
Solar Explochem acquired Sivasakthi Industrial Explosives for ₹115 Cr. Tuck-in deal to expand explosives capacity and product range in India.
Sivasakthi Acquisition
Sep 29
Solar Explochem Proprietary Limited incorporated in Botswana. Part of broader geopolitical expansion in Africa; international footprint build.
Botswana Subsidiary
Sep 29
Standard SEBI-mandated closure for Q2 results. No unusual insider activity flagged.
Trading Window Closure
Sep 14
Major: Solar SA Investments (subsidiary) to acquire South Africa's Omnia Holdings for $1.355B (₹12,951 Cr). Defence + explosives play; diversification into South African market and SADC region.
Omnia Holdings Acquisition
Aug 13
Record quarter: ₹3,668 Cr revenue (+70% YoY), ₹666 Cr PAT (+89% YoY). Management maintained ₹14,000 Cr FY27 revenue target; hiked defence guidance 50%.
Q1 FY27 Results
The Omnia deal is the headline. At ~₹12,951 Cr (or ~$1.355B), it's a material acquisition—roughly 8–9 months of annualized FY26 revenue—signaling ambition to build a global defence explosives and mining chemicals franchise. The deal is expected to close in H1 FY28, so Q2 results will not reflect Omnia's earnings, but management may discuss integration timelines and synergies. The Sivasakthi tuck-in (₹115 Cr) is routine capacity expansion. The Botswana subsidiary is part of the Africa footprint rollout post-Omnia.
1 · Defence revenue acceleration
Is Q2 defence revenue tracking the ₹4,500 Cr FY27 guidance? Look for the absolute number and YoY/QoQ growth rate. If it's +40–50%, the thesis holds. If it dips below +30%, execution risk rises.
2 · Margin narrative
Can Solar hold ₹18%+ net margins despite Omnia integration costs and raw-material inflation? If PAT margin dips to 16% or below, either working-capital is tightening or there's unannounced headwind. Management commentary on FY27 margin guidance will be critical.
3 · Omnia timeline & synergies
Even though the deal closes in H1 FY28, management will likely discuss expected accretion and cost synergies post-close. A vague or conservative outlook could trigger valuation rerating.
4 · Order book & forward visibility
The June order book was ₹21,350 Cr. Q2 results will show inflows and conversions. Any material slowdown in order inflows would be a yellow flag for FY28 growth.
Solar Industries enters Q2 FY27 as a momentum play on India's defence indigenization and international expansion. Q1 set a high bar (₹3,668 Cr, +70% YoY; ₹666 Cr PAT, +89% YoY), and the Street expects repetition. With a ₹21,350 Cr order book and a raised defence-revenue guidance of ₹4,500 Cr (+50%), the company has visibility. The Omnia acquisition ($1.355B), announced mid-cycle, is a strategic bet on global scale. Q2 will test whether Solar can sustain momentum while managing integration prep and raw-material inflation.
Key numbers to watch: revenue ~₹3,500 Cr (on-plan if momentum holds), PAT ~₹600 Cr (test of margin stability), and defence revenue confirmation of the +50% FY27 thesis. The consensus is bullish (Buy, 9.8% upside), but execution risk is real—especially if the company signals any near-term headwinds or delays in order conversions.
Informational and educational content only. Not investment advice.